Treatment of CIA mice with 12 mitigated joint destruction and other clinical RA manifestations, downregulated NF-κB and reduced the IL-1β-induced expressions of TNF-α, IL-6, IL-8, MMP-1 and MMP-3 [90]. The gene discussed is NFKB1; the disease is rheumatoid arthritis.